10x Genomics, Inc. Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year
10x Genomics, Inc. (TXG) had Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year of $645.00 thousand as of 2021-09-30, per its 10-Q filed 2021-11-05.
Discontinued › Notes
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear · last filed 2021-11-05
- 2021-09-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $645.00K.
- 2021-06-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $1.30M.
- 2021-03-31: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $1.95M.
- 2020-09-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $455.00K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year |
|---|---|
| 2021-09-30 | $645.00K 10-Q · filed 2021-11-05 |
| 2021-06-30 | $1.30M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $1.95M 10-Q · filed 2021-05-07 |
| 2020-09-30 | $455.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $815.00K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $1.22M 10-Q · filed 2020-05-12 |